Title:
アリール基が結合したアザポリサイクリック化合物
Document Type and Number:
Japanese Patent JP2005510568
Kind Code:
A
Abstract:
This invention is directed to compounds of the formula (I):and their pharmaceutically acceptable salts, wherein R<1>, R<2>, and R<3 >are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of nicotine addiction/withdrawal and CNS disorders.
Inventors:
Obach, Ronald Scott
Anne Elizabeth, Hagen
Anne Elizabeth, Hagen
Application Number:
JP2003547416A
Publication Date:
April 21, 2005
Filing Date:
November 18, 2002
Export Citation:
Assignee:
Pfizer Products Inc.
International Classes:
C07H13/10; A61K31/4985; A61K31/706; A61P1/00; A61P1/04; A61P1/06; A61P1/12; A61P3/04; A61P9/06; A61P9/08; A61P17/00; A61P21/02; A61P25/02; A61P25/08; A61P25/12; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P25/34; A61P29/00; A61P43/00; C07D471/04; C07H7/033; C07H13/12; C07H19/23; (IPC1-7): C07D471/04; A61K31/4985; A61K31/706; A61P1/00; A61P1/04; A61P1/06; A61P1/12; A61P3/04; A61P9/06; A61P9/08; A61P17/00; A61P21/02; A61P25/02; A61P25/08; A61P25/12; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P25/34; A61P29/00; A61P43/00; C07H13/10; C07H19/23
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Tetsuji Koga
Kazuhiro Nakamura
Masaya Nishiyama
Takashi Ishida
Tetsuji Koga
Kazuhiro Nakamura
Masaya Nishiyama